Policy
Calculator

Pilot-Phase

1. 'Did you have flu last week?’ A telephone survey to estimate a point prevalence of influenza in the Swedish population;
2. 2014 Failed Influenza Vaccination Winter Campaign;
3. 2019 Influenza Vaccination Campaign in an Italian Research and Teaching Hospital;
4. A campaign aimed at increasing seasonal influenza vaccination coverage among post graduate medical residents in an Italian teaching hospital;
5. A cloud-based simulation architecture for pandemic influenza simulation;
6. A comparative analysis of influenza vaccination programs;
7. A discrete time-space geography for epidemiology;
8. A flexible simulation architecture for pandemic influenza simulation;
9. A global map of hemispheric influenza vaccine recommendations based on local patterns of viral circulation;
10. A neighborhood susceptibility index for planning of local physical interventions in response to pandemic influenza outbreaks;
11. A network strategy to advance public health in Europe;
12. A pneumococcal pneumonia and influenza vaccination quality improvement program for women receiving chemotherapy for gynecologic cancers at a major tertiary cancer Centre;
13. A randomized trial of maternal influenza immunization decision-making;
14. A review of the pharmacist as vaccinator;
15. A systematic review of the health economic consequences of quadrivalent influenza vaccination;
16. Age as a determinant for dissemination of seasonal and pandemic influenza;
17. Algorithms for detecting and predicting influenza outbreaks;
18. An assessment of the expected cost-effectiveness of quadrivalent influenza vaccines in Ontario, Canada using a static model;
19. An effective strategy for influenza vaccination of healthcare workers in Australia;
20. An evaluation of the 2016 influenza vaccination in pregnancy campaign in NSW, Australia;
21. An intensive 5-year-long influenza vaccination campaign is effective among doctors but not nurses;
22. An overview of current pharmacy impact on immunisation - A global report;
23. Annual public health and economic benefits of seasonal influenza vaccination: a European estimate;
24. Approaches to the vaccination of pregnant women;
25. Are age-based strategies effective in increasing influenza vaccination coverage? The Spanish experience;
26. Association between recruitment methods and attrition in internet-based studies;
27. Association of acute myocardial infarction with influenza;
28. Association of state laws and healthcare workers' influenza vaccination rates;
29. Attitudes and beliefs on influenza vaccination during the covid-19 pandemic;
30. Attitudes and perception of healthcare workers concerning influenza vaccination during the 2019/2020 season;
31. Attractive VCR-linked financial incentive for HCP;
32. Brief education to promote maternal influenza vaccine uptake;
33. Burden of medically attended influenza in Norway 2008-2017;
34. Campaign, counseling and compliance with influenza vaccine among older persons;
35. Changing the default to promote influenza vaccination among health care workers;
36. Chasing seasonal influenza — The need for a universal influenza vaccine;
37. Closure of schools during an influenza pandemic;
38. Cluster randomized trial of a toolkit and early vaccine delivery to improve childhood influenza vaccination rates in primary care;
39. Communicable diseases prioritized according to their public health relevance;
40. Consultations for Influenza-Like Illness in Primary Care in The Netherlands: A Regression Approach;
41. Contemporary vaccination policy in the European Union;
42. Correlation between mandatory influenza vaccination for healthcare;
43. Cost-effectiveness of influenza vaccination of elderly in Sweden;
44. Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy;
45. Costs and effectiveness of influenza vaccination;
46. Dealing with ecological fallacy in preparations for influenza pandemics;
47. Description of the Western Sydney and Nepean Blue Mountains local health districts’ influenza prevention programme;
48. Determinants of fatal outcome in patients admitted to intensive care units with influenza;
49. Determinants of follow-up participation in the internet-based european influenza surveillance platform influenzanet;
50. Determinants of influenza vaccination uptake among Italian healthcare workers;
51. Developing a program to increase seasonal influenza vaccination of healthcare workers: lessons from a system of community hospitals;
52. Does viral interference affect spread of influenza?;
53. Duration of influenza vaccine effectiveness;
54. Dynamic multicore processing for pandemic influenza simulation;
55. ECDC Threat Assessment Influenza of possible swine origin in human in Spain;
56. Economic consequences to society of pandemic H1N1 influenza 2009 - preliminary results for Sweden;
57. Effect of a text messaging intervention on influenza vaccination in an urban, low-income pediatric and adolescent population;
58. Effect of mass paediatric influenza vaccination on existing influenza vaccination programmes in England and Wales;
59. Effect of motivational team on influenza vaccination coverage among health care workers;
60. Effectiveness and acceptance of a health care-based mandatory vaccination program;
61. Effectiveness of a multimodal intervention to increase vaccination in obstetrics/gynecology settings;
62. Effectiveness of age-based strategies to increase influenza vaccination coverage among high risk subjects in Madrid (Spain);
63. Effectiveness of an educational intervention on seasonal influenza vaccination campaign adherence among healthcare workers of the Palermo University Hospital, Italy;
64. Effectiveness of an intervention campaign on influenza vaccination of professionals in nursing homes;
65. Effectiveness of influenza vaccines in preventing severe influenza illness among adults;
66. Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly;
67. Effectiveness of the influenza vaccination program for the elderly in Taiwan;
68. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10;
69. Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults;
70. Efficacy and effectiveness of influenza vaccines;
71. Efficacy and safety of high-dose influenza vaccine in elderly adults;
72. Emergency Department influenza vaccination campaign allows increasing influenza vaccination coverage without disrupting time interval quality indicators;
73. Employee influenza vaccination in a large cancer center with high baseline compliance rates;
74. Epidemiologic and economic impact of pharmacies as vaccination locations during an influenza epidemic;
75. Estimated costs associated with improving influenza vaccination for health care personnel in a multihospital health system;
76. Estimating the annual attack rate of seasonal influenza among unvaccinated individuals: A systematic review and meta-analysis;
77. Ethical approaches to mandating inflfluenza vaccinations for local health department workforce in Georgia;
78. European all-cause excess and influenza-attributable mortality in the2017/18 season;
79. Evaluating costs and health consequences of sick leave strategies against pandemic and seasonal influenza in Norway using a dynamic model;
80. Evaluating influenza vaccination campaigns beyond coverage;
81. Evaluating the importance of policy amenable factors in explaining influenza vaccination;
82. Evaluation of a city-wide school-located influenza vaccination program in Oakland, California, with respect to vaccination coverage, school absences, and laboratory-confirmed influenza;
83. Evaluation of an internet-based monitoring system for influenza-like illness in Sweden;
84. Evaluation of employee vaccination policies in outpatient oncology clinics;
85. Evaluation of nowcasting for detecting and predicting local influenza epidemics, Sweden, 2009–2014;
86. Evaluation of the Canterbury under-18 seasonal influenza vaccination programme;
87. Evaluation of the impact of immunization policies, including the addition of pharmacists as immunizers, on influenza vaccination coverage in Nova Scotia, Canada: 2006 to 2016;
88. Evaluation of the impact of the 2012 Rhode Island health care worker influenza vaccination regulations;
89. Examination of the British Columbia influenza prevention policy for healthcare workers;
90. Exploring indirect protection associated with influenza immunization;
91. Extensive hospital in-ward clustering revealed by molecular characterization of influenza a virus infection;
92. Feasibility and acceptability of the multi-component P3-MumBubVax antenatal intervention to promote maternal and childhood vaccination: A pilot study;
93. Feasibility of a pharmacy-based influenza immunization program in an academic emergency department;
94. Flocked nasal swab versus nasopharyngeal aspirate in adult emergency room patients;
95. Flu vaccination - The gap between evidence and public policy;
96. Gender, Socioeconomic, and Health Characteristics Associated with Influenza Vaccination Coverage (VC) among Italian Healthcare Workers: Secondary Analysis of a National Cross-Sectional Survey;
97. General practitioners perceptions about financial and non-financial incentives to improve influenza vaccination coverage rates in France;
98. GP procurement for the flu vaccination programme;
99. Health services utilization, work absenteeism and costs of pandemic influenza A (H1N1) 2009 in Spain: a multicenter-longitudinal study;
100. Healthcare worker influenza declination form program;
101. High added value of a population-based participatory surveillance system for community acute gastrointestinal, respiratory and influenza-like illnesses in Sweden;
102. High prevalence of influenza A virus in ducks caught during spring migration through Sweden;
103. Higher all-cause mortality in children during autumn 2009 compared with the three previous years;
104. Hospital-based cluster randomised controlled trial to assess effects of a multi-faceted programme on influenza vaccine coverage among hospital healthcare workers and nosocomial influenza in the Netherlands;
105. How to implement seasonal influenza vaccination of health workers;
106. How to respond to vocal vaccine deniers in public;
107. Human cases of avian influenza in eastern Turkey;
108. Immunisation of healthcare workers in the Nordic countries: Variation in recommendations and practices and a lack of assessment;
109. Immunization of health-care providers - Necessity and public health policies;
110. Impact of education program on influenza vaccination rates in Spain;
111. Impact of elementary school-located influenza vaccinations;
112. Impact of national influenza vaccination strategy in severe influenza outcomes among the high-risk Portuguese population;
113. Impact of pharmacist administration of influenza vaccines on uptake in Canada;
114. Impact of pharmacist immunization authority on seasonal influenza immunization rates across states;
115. Impact of pharmacists as immunizers on influenza vaccination coverage in Nova Scotia, Canada;
116. Impact of pharmacy-initiated interventions on influenza vaccination rates in pediatric solid organ transplant recipients;
117. Impact of precautionary behaviors during outbreaks of pandemic influenza;
118. Impact of the flu mask regulation on health care personnel influenza vaccine acceptance rates;
119. Impact of the GP contract on inequalities associated with influenza immunisation;
120. Impacting delayed pediatric influenza vaccination;
121. Implementation of a mandatory influenza vaccine policy- a 10-year experience;
122. Implementation of the Council Recommendation on seasonal influenza vaccination (2009/1019/EU);
123. Improving influenza vaccination coverage among patients with COPD;
124. Improving influenza vaccination rates of healthcare workers;
125. Improvinginfluenzavaccinationuptakeamonghealthcareworkersbyon- site influenza vaccination campaign in a tertiary children hospital;
126. Improving Influenza vaccine uptake in frontline staff;
127. Incidence, etiology, and outcomes of community-acquired pneumonia;
128. Inclusion of social media-based strategies in a health care worker influenza immunization campaign;
129. Increases in vaccination coverage of healthcare personnel following institutional requirements for influenza vaccination: a national survey of U.S. hospitals;
130. Increasing childhood influenza vaccination;
131. Increasing influenza and pneumococcal vaccination uptake in seniors using point-of-care informational interventions in primary care in Singapore;
132. Increasing influenza immunization rates among healthcare providers in an ambulatory-based, University healthcare setting;
133. Increasing influenza vaccination acceptance in the homeless;
134. Increasing influenza vaccination rates via low cost messaging interventions;
135. Increasing influenza vaccine uptake in children;
136. Increasing inner-city adult influenza vaccination rates;
137. Inference principles for multivariate surveillance;
138. Influenza burden of illness: estimates from a national prospective survey of household contacts in France;
139. Influenza coverage rates in subjects with chronic heart diseases;
140. Influenza detection and prediction algorithms;
141. Influenza in Sweden 2018–2019 Season;
142. Influenza in Sweden 2019–2020 Season;
143. Influenza vaccination and its association with clinic use of evidence- based practices and individual patient characteristics;
144. Influenza Vaccination Coverage Among Health Care Personnel;
145. Influenza vaccination coverage among high-risk groups in 11 European countries;
146. Influenza vaccination coverage among splenectomized patients;
147. Influenza vaccination coverage of health care personnel in Los Angeles County hospitals;
148. Influenza vaccination in health-care workers;
149. Influenza Vaccination in Italian Healthcare Workers (2018-2019 Season): Strengths and Weaknesses. Results of a Cohort Study in Two Large Italian Hospitals;
150. Influenza vaccination in Turkey: Prevalence of risk groups, current vaccination status, factors influencing vaccine uptake and steps taken to increase vaccination rate;
151. Influenza vaccination of health care workers - Policies and practices of hospitals in a community setting;
152. Influenza vaccination of healthcare workers in Italy - could mandatory vaccination be a solution to protect patients;
153. Influenza vaccination of schoolchildren and influenza outbreaks in a school;
154. Influenza vaccination strategies for 2020-21 in the context of COVID-19;
155. Influenza vaccination: Key facts for general practitioners in Europe;
156. Influenza vaccine coverage and reasons for non-vaccination in a sample of people above 65 years of age;
157. Influenza vaccine effectiveness against influenza-associated hospitalization in children;
158. Influenza vaccine effectiveness among high-risk groups: A systematic literature review and meta-analysis of case-control and cohort studies; 159. Influenza vaccines: Evaluation of the safety profile;
159. Influenza-related healthcare visits, hospital admissions, and direct medical costs for all children aged 2 to 17 years in a defined Swedish region, monitored for 7 years;
160. Initial epidemiological finding in the european union following the declaration of pandemic alert level 5 due to influenza A(H1N1);
161. Integrated detection and prediction of influenza activity for real-time surveillance;
162. Intentions to perform non-pharmaceutical protective behaviors during influenza outbreaks in Sweden;
163. Interactive Voice Response and web-based questionnaires for population-based infectious disease reporting;
164. Interim 2019/20 influenza vaccine effectiveness: six European studies, September 2019 to January 2020;
165. Intervening to reduce inequalities in infections in Europe;
166. Interventions to increase influenza vaccination rates in children with
167. high-risk conditions;
168. Key policy and programmatic factors to improve influenza vaccination rates based on the experience from four high-performing countries;
169. Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels;
170. Let’s talk about hesitancy;
171. Management of community-acquired pneumonia in immunocompetent adults;
172. Management of two influenza vaccination campaign in health care workers of a university hospital in the south Italy;
173. Mandated influenza vaccines and health care workers’ autonomy;
174. Mandating influenza vaccinations for health care workers;
175. Mandatory influenza vaccination of healthcare workers: a 5-year study;
176. Mandatory policies for influenza vaccination;
177. MandatoryseasonalinfluenzavaccinationormaskingofBritish Columbia health care workers;
178. Mandatory vaccination for health care workers;
179. Maximising the public health benefits of vaccination;
180. Maximizing influenza vaccination uptake among healthcare personnel in Israel;
181. Minority of U.S. hospitals mandate flu vaccination;
182. Modeling influenza incidence for the purpose of on-line monitoring;
183. Modelling estimates of age-specific influenza-related hospitalisation and mortality in the United Kingdom;
184. Modelling the optimal target age group for seasonal influenza vaccination in Japan;
185. Moving the needle on nursing staff influenza vaccination in long-term care;
186. Multicomponent interventions to enhance influenza vaccine delivery to adolescents;
187. Multiplex real-time PCR for detection of respiratory tract infections;
188. Multivariate outbreak detection;
189. National Board of Health and Welfare – database;
190. Novel influenza a(H1n2) seasonal reassortant identified in a patient sample;
191. Nowcasting (short-term forecasting) of influenza epidemics in local settings, Sweden, 2008–2019;
192. Number needed to vaccinate to prevent hospitalizations of pregnant women due to inter-pandemic influenza in Sweden;
193. Ontology based modeling of pandemic simulation scenarios;
194. Optimizing influenza vaccine distribution;
195. Pandemic Influenza A(H1N1)pdm09 seroprevalence in Sweden before and after the pandemic and the vaccination campaign in 2009;
196. Pandemic vaccination strategies and influenza severe outcomes during the influenza A(H1N1)pdm09 pandemic and the post-pandemic influenza season;
197. Panel of international experts concludes on influenza and pneumococcal vaccination in Europe;
198. Patient experiences with influenza immunizations administered by pharmacists;
199. Patient’s behaviors and missed opportunities for vaccination against seasonal epidemic influenza and evaluation of their impact on patient’s influenza vaccine uptake;
200. Performance of ehealth data sources in local influenza surveillance;
201. Pharmacists able to update GP patient records with flu vaccine data from winter 2019;
202. Pharmacy-based interventions to increase vaccine uptake: Report of a multidisciplinary stakeholders meeting;
203. Point of care experience with pneumococcal and influenza vaccine documentation among persons aged 65 years;
204. Population-based simulations of influenza pandemics;
205. Predictions by early indicators of the time and height of the peaks of yearly influenza outbreaks in Sweden;
206. Predictive performance of telenursing complaints in influenza surveillance;
207. Prevailing effectiveness of the 2009 influenza A(H1N1)pdm09 vaccine during the 2010/11 season in Sweden;
208. Prevention and control of seasonal influenza with vaccines;
209. Promoting influenza vaccination among an ACA Health Plan subscriber population;
210. Promotion of flu vaccination among healthcare workers in an Italian academic hospital;
211. Promotion of influenza vaccination among health care workers;
212. Prospective evaluation of a novel multiplex real-time PCR assay for detection of fifteen respiratory pathogens;
213. Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe;
214. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine;
215. Quadrivalent inactivated influenza vaccine (VaxigripTetraTM);
216. Randomised controlled trial of a theory-based intervention to prompt front-line staff to take up the seasonal influenza vaccine;
217. Randomized controlled trial of text message reminders for increasing influenza vaccination;
218. Randomized controlled trial on promoting influenza vaccination in general practice waiting rooms;
219. RCT of centralized vaccine reminder/recall for adults;
220. Recommendations for mandatory influenza vaccinations for health care personnel from AMDA’s infection advisory subcommittee;
221. Reducing racial disparities in influenza vaccination among children with asthma;
222. Relevance of workplace social mixing during influenza pandemics;
223. Respiratory viruses associated with community acquired pneumonia in children;
224. Risk factors for serious outcomes associated with influenza illness in high- versus low- and middle-income countries: Systematic literature review and meta-analysis;
225. Robust outbreak surveillance of epidemics in Sweden;
226. School-based influenza vaccination: Health and economic impact of Maine’s 2009 Influenza Vaccination Program;
227. School-located influenza vaccination decreases laboratory-confirmed influenza and improves school attendance;
228. School-located influenza vaccinations for adolescents
229. Seasonal influenza vaccination delivery through community pharmacists in England;
230. Seasonal influenza vaccination in health care workers;
231. Seasonal influenza vaccine dose distribution in 195 countries (2004-2013): Little progress in estimated global vaccination coverage;
232. Seasonal influenza vaccine procurement systems in Europe;
233. Seasonal influenza vaccine uptake and vaccine refusal among pregnant women in France: results from a national survey;
234. Seasonality and geographical spread of respiratory syncytial virus epidemics in 15 European countries;
235. Self-sampling for analysis of respiratory viruses in a large-scale epidemiological study in Sweden;
236. Semiparametric estimation of outbreak regression;
237. Semiparametric surveillance of monotonic changes;
238. Semiparametric surveillance of outbreaks;
239. Simulation as decision support in pandemic influenza preparedness and response;
240. SMS versus telephone interviews for epidemiological data collection;
241. Socioecological and message framing factors influencing maternal influenza immunization among minority women;
242. Some model based considerations on observing generation times for communicable diseases;
243. Spatial outbreak detection based on inference principles for multivariate surveillance;
244. Statistical surveillance of epidemics;
245. Strategies to improve influenza vaccination in pediatric inflammatory bowel disease through education and access;
246. Support among healthcare workers for the new mandatory seasonal influenza vaccination policy and its effects on vaccination coverage;
247. Surveillance of influenza A virus in migratory waterfowl in northern Europe;
248. Swedish nursing and medical students’ high vaccination adherence during the influenza A (H1N1) pandemic 2009;
249. Taking action on asthma;
250. Text messages for influenza vaccination among pregnant women;
251. The case for tracking misinformation the way we track disease;
252. The effect of influenza vaccination for the elderly on hospitalization and mortality;
253. The European Scientific Conference on applied infectious disease epidemiology;
254. The impact of European vaccination policies on seasonal influenza vaccination coverage rates in the elderly;
255. The impact of influenza vaccination requirements for hospital personnel in California;
256. The impact of new universal child influenza programs in Australia: Vaccine coverage, effectiveness and disease epidemiology in hospitalised children in 2018;
257. The importance of confidence, complacency, and convenience for influenza vaccination among key risk groups in large urban areas of Peru;
258. The Occupational Risk of Influenza A (H1N1) Infection among Healthcare Personnel during the 2009 Pandemic: A Systematic Review and Meta-Analysis of Observational Studies;
259. The representativeness of a European multi-center network for influenza-like-illness participatory surveillance;
260. The validity of self-initiated, event-driven infectious disease reporting in general population cohorts;
261. Towards a simulation environment for modeling of local influenza outbreaks;
262. Treatment and prevention of influenza: Swedish recommendations;
263. Understanding non-vaccinating parents’ views to inform and improve clinical encounters;
264. Universal influenza vaccination among healthcare personnel;
265. Uptake of childhood influenza vaccine from 2012-2013 to 2014-2015 in the UK and the implications for high-risk children;
266. Uptake of funded influenza vaccines in young Australian children in 2018;
267. Using general practice data to monitor influenza vaccination coverage in the medically at risk;
268. Using technology to affect influenza vaccine coverage among children with chronic respiratory conditions;
269. Using the 4 Pillars to increase vaccination among high-risk adults;
270. Vaccination and trust;
271. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons;
272. Vaccination rates are associated with functional proximity but not base proximity of vaccination clinics;
273. Vaccination strategies against COVID-19 and the diffusion of anti- vaccination views;
274. Vaccination without litigation — addressing religious objections to hospital influenza-vaccination mandates;
275. Vaccine cold chain in general practices: A prospective study in 75 refrigerators (Keep Cool study);
276. Vaccine hesitancy and healthcare providers;
277. Vaccine instability in the cold chain: Mechanisms, analysis and formulation strategies;
278. Vaccines for preventing influenza in healthy adults;
279. Vaccines for preventing influenza in healthy children;
280. Vaccines for preventing influenza in the elderly;
281. Variable influenza vaccine effectiveness by subtype;
282. Visual inspection of vaccine storage conditions in general practices: A study of 75 vaccine refrigerators;
283. Visualization of infectious disease outbreaks in routine practice;
284. Web-based participatory surveillance of infectious diseases;
285. What evidence is there for mandatory flu vaccination for healthcare workers?;
286. Why are Mexican data important?
      

German-related literature

1. Arlt, J., Flaegel, K., Goetz, K., & Steinhaeuser, J. (2021). Regional differences in general practitioners’ behaviours regarding influenza vaccination: a cross-sectional study. BMC Health Services Research, 21(1). https://doi.org/10.1186/s12913-021-06177-x

2. Atkins K, van Hoek AJ, Watson C, Baguelin M, Choga L, Patel A, Raj T, Jit M, Griffiths U. Seasonal influenza vaccination delivery through community pharmacists in England: evaluation of the London pilot. BMJ Open. 2016 Feb 16;6(2):e009739. doi: 10.1136/bmjopen-2015-009739. PMID: 26883237; PMCID: PMC4762088.

3. Badmus D, Menzies R. Using general practice data to monitor influenza vaccination coverage in the medically at risk: a data linkage study. BMJ Open. 2019 Sep 17;9(9):e031802. doi: 10.1136/bmjopen-2019-031802. PMID: 31530622; PMCID: PMC6756341.

4. Baggio, M., Krawczyk, M., & Baggio, M. (2023). Vaccination demand and acceptance. https://doi.org/10.2760/420996

5. Barratt, J., & Bouzanis, K. (2022). Influencing Adult Pneumonia Vaccination Policy.

6. Baxter D. Approaches to the vaccination of pregnant women: experience from Stockport, UK, with prenatal influenza. Hum Vaccin Immunother. 2013 Jun;9(6):1360-3. doi: 10.4161/hv.25525. Epub 2013 Jun 24. PMID: 23857270; PMCID: PMC3901831.

7. Benjamin-Chung J, Arnold BF, Kennedy CJ, Mishra K, Pokpongkiat N, Nguyen A, Jilek W, Holbrook K, Pan E, Kirley PD, Libby T, Hubbard AE, Reingold A, Colford JM Jr. Evaluation of a city-wide school-located influenza vaccination program in Oakland, California, with respect to vaccination coverage, school absences, and laboratory-confirmed influenza: A matched cohort study. PLoS Med. 2020 Aug 18;17(8):e1003238. doi: 10.1371/journal.pmed.1003238. PMID: 32810149; PMCID: PMC7433855.

8. Böhm, S., Röbl-Mathieu, M., Scheele, B. et al. Influenza and pertussis vaccination during pregnancy - attitudes, practices and barriers in gynaecological practices in Germany. BMC Health Serv Res 19, 616 (2019). https://doi.org/10.1186/s12913-019-4437-y

9. Böhmer, M. M., Walter, D., Falkenhorst, G., Müters, S., Krause, G., & Wichmann, O. (2012). Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany. BMC Public Health, 12(1). https://doi.org/10.1186/1471-2458-12-938

10. Bonanni, P., Steffen, R., Schelling, J., Balaisyte-Jazone, L., Posiuniene, I., Zatoński, M., & Van Damme, P. (2023). Vaccine co-administration in adults: An effective way to improve vaccination coverage. Human Vaccines & Immunotherapeutics, 19(1). https://doi.org/10.1080/21645515.2023.2195786

11. Borgey F, Henry L, Lebeltel J, Lescure P, Le Coutour X, Vabret A, Verdon R, Thibon P. Effectiveness of an intervention campaign on influenza vaccination of professionals in nursing homes: A cluster-randomized controlled trial. Vaccine. 2019 Feb 28;37(10):1260-1265. doi: 10.1016/j.vaccine.2019.01.066. Epub 2019 Feb 7. PMID: 30738645.

12. Brachmann, M., Serwa, P. & Sauerland, D. Cost-of-illness comparison between clinical judgment and molecular point-of-care testing for influenza-like illness patients in Germany. npj Prim. Care Respir. Med. 33, 3 (2023). https://doi.org/10.1038/s41533-022-00325-4

13. Brixner, A., Brandstetter, S., Böhmer, M. M., Seelbach-Göbel, B., Melter, M., Kabesch, M., & Apfelbacher, C. (2021). Prevalence of and factors associated with receipt of provider recommendation for influenza vaccination and uptake of influenza vaccination during pregnancy: cross-sectional study. BMC Pregnancy and Childbirth, 21(1). https://doi.org/10.1186/s12884-021-04182-w

14. Buchan SA, Rosella LC, Finkelstein M, Juurlink D, Isenor J, Marra F, Patel A, Russell ML, Quach S, Waite N, Kwong JC; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Program Delivery and Evaluation Group. Impact of pharmacist administration of influenza vaccines on uptake in Canada. CMAJ. 2017 Jan 30;189(4):E146-E152. doi: 10.1503/cmaj.151027. Epub 2016 Aug 8. PMID: 27503864; PMCID: PMC5266568.

15. Calder K, Bidwell S, Brunton C, Pink R. Evaluation of the Canterbury under-18 seasonal influenza vaccination programme. N Z Med J. 2014 Jul 18;127(1398):19-27. PMID: 25146858.

16. Chaves SS, Nealon J, Burkart KG, Modin D, Biering-Sørensen T, Ortiz JR, Vilchis-Tella VM, Wallace LE, Roth G, Mahe C, Brauer M. Global, regional and national estimates of influenza-attributable ischemic heart disease mortality. EClinicalMedicine. 2022 Nov 18;55:101740. doi: 10.1016/j.eclinm.2022.101740. PMID: 36425868; PMCID: PMC9678904.

17. Colombo L, Witte J, Gensorowsky D, Batram M, Hadigal S. Out of focus but still relevant? Influenza-related resource utilization and vaccination coverage gaps in adults below 60 years of age with underlying conditions: an analysis of 2016-2024 real-world data in Germany. J Med Econ. 2024 Jan-Dec;27(1):1337-1346. doi: 10.1080/13696998.2024.2413284. Epub 2024 Oct 18. PMID: 39376163.

18. Damm O, Krefft A, Ahlers J, Kramer R, Witte J, Batram M, Schelling J, Greiner W. Prevalence of chronic conditions and influenza vaccination coverage rates in Germany: Results of a health insurance claims data analysis. Influenza Other Respir Viruses. 2023 Jan;17(1):e13054. doi: 10.1111/irv.13054. Epub 2022 Oct 1. PMID: 36181357; PMCID: PMC9835435.

19. Damm, O., Krefft, A., Ahlers, J., Kramer, R., Witte, J., Batram, M., Schelling, J., & Greiner, W. (2023). Prevalence of chronic conditions and influenza vaccination coverage rates in Germany: Results of a health insurance claims data analysis. Influenza and Other Respiratory Viruses, 17(1). https://doi.org/10.1111/irv.13054

20. de Fougerolles, T. R., Damm, O., Ansaldi, F., Chironna, M., Crépey, P., de Lusignan, S., Gray, I., Guillen, J. M., Kassianos, G., Mosnier, A., de Lejarazu, R. O., Pariani, E., Puig-Barbera, J., Schelling, J., Trippi, F., Vanhems, P., Wahle, K., Watkins, J., Rasuli, A., … Bricout, H. (2022). National influenza surveillance systems in five European countries: a qualitative comparative framework based on WHO guidance. BMC Public Health, 22(1). https://doi.org/10.1186/s12889-022-13433-0

21. Demicheli V, Jefferson T, Di Pietrantonj C, Ferroni E, Thorning S, Thomas RE, Rivetti A. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD004876. doi: 10.1002/14651858.CD004876.pub4. PMID: 29388197; PMCID: PMC6491101.

22. Demicheli V, Jefferson T, Ferroni E, Rivetti A, Di Pietrantonj C. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD001269. doi: 10.1002/14651858.CD001269.pub6. PMID: 29388196; PMCID: PMC6491184.

23. Dolk FCK, de Boer PT, Nagy L, et al. Consultations for Influenza-Like Illness in Primary Care in The Netherlands: A Regression Approach. Value Health. Jan 2021;24(1):11-18. doi:10.1016/j.jval.2020.10.013

24. Drees M, Wroten K, Smedley M, Mase T, Schwartz JS. Carrots and sticks: achieving high healthcare personnel influenza vaccination rates without a mandate. Infect Control Hosp Epidemiol. 2015 Jun;36(6):717-24. doi: 10.1017/ice.2015.47. Epub 2015 Feb 27. PMID: 25721404.

25. Drozd EM, Miller L, Johnsrud M. Impact of Pharmacist Immunization Authority on Seasonal Influenza Immunization Rates Across States. Clin Ther. 2017 Aug;39(8):1563-1580.e17. doi: 10.1016/j.clinthera.2017.07.004. Epub 2017 Aug 7. PMID: 28781217.

26. ECDC. (2015). Seasonal influenza vaccination programme country profile: Germany. https://ec.europa.eu/CensusHub2/intermediate.do?&method=forwardResult

27. Edwards F, Masick KD, Armellino D. Impact of the flu mask regulation on health care personnel influenza vaccine acceptance rates. Am J Infect Control. 2016 Oct 1;44(10):1154-1157. doi: 10.1016/j.ajic.2016.03.006. Epub 2016 Apr 19. PMID: 27106163.

28. EFPIA. (2017). Report on the sources for usage of specific influenza vaccine brands and accessibility.

29. EOHSP. (2018). The organization and delivery of vaccination services in the European Union Prepared for the European Commission. www.healthobservatory.eu

30. Eurostat (2022) Healthcare activities statistics - consultations. https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Healthcare_activities_statistics_-_consultations

31. Faivre, P., Benčina, G., Campbell, R., Quilici, S., Dauby, N., Tešović, G., Bonanni, P., & Drury, R. (2021). Immunization funding across 28 European countries. In Expert Review of Vaccines (Vol. 20, Issue 6, pp. 639-647). Taylor and Francis Ltd. https://doi.org/10.1080/14760584.2021.1905257

32. Frawley JE, McManus K, McIntyre E, Seale H, Sullivan E. Uptake of funded influenza vaccines in young Australian children in 2018; parental characteristics, information seeking and attitudes. Vaccine. 2020 Jan 10;38(2):180-186. doi: 10.1016/j.vaccine.2019.10.033. Epub 2019 Oct 23. PMID: 31668365.

33. Frew PM, Kriss JL, Chamberlain AT, Malik F, Chung Y, Cortés M, Omer SB. A randomized trial of maternal influenza immunization decision-making: A test of persuasive messaging models. Hum Vaccin Immunother. 2016 Aug 2;12(8):1989-1996. doi: 10.1080/21645515.2016.1199309. PMID: 27322154; PMCID: PMC4994759.

34. Frew PM, Saint-Victor DS, Owens LE, Omer SB. Socioecological and message framing factors influencing maternal influenza immunization among minority women. Vaccine. 2014 Mar 26;32(15):1736-44. doi: 10.1016/j.vaccine.2014.01.030. Epub 2014 Jan 28. PMID: 24486366.

35. Friedl A, Aegerter C, Saner E, Meier D, Beer JH. An intensive 5-year-long influenza vaccination campaign is effective among doctors but not nurses. Infection. 2012 Feb;40(1):57-62. doi: 10.1007/s15010-011-0193-6. Epub 2011 Sep 29. PMID: 21956456.

36. Gargano LM, Pazol K, Sales JM, Painter JE, Morfaw C, Jones LM, Weiss P, Buehler JW, Murray DL, Wingood GM, Orenstein WA, DiClemente RJ, Hughes JM. Multicomponent interventions to enhance influenza vaccine delivery to adolescents. Pediatrics. 2011 Nov;128(5):e1092-9. doi: 10.1542/peds.2011-0453. Epub 2011 Oct 10. PMID: 21987709; PMCID: PMC3387882.

37. Gattis S, Yildirim I, Shane AL, Serluco S, McCracken C, Liverman R. Impact of Pharmacy-Initiated Interventions on Influenza Vaccination Rates in Pediatric Solid Organ Transplant Recipients. J Pediatric Infect Dis Soc. 2019 Dec 27;8(6):525-530. doi: 10.1093/jpids/piy095. PMID: 30307524.

38. Geiger, M., Rees, F., Lilleholt, L., Santana, A. P., Zettler, I., Wilhelm, O., … Böhm, R. (2022). Measuring the 7Cs of Vaccination Readiness. European Journal of Psychological Assessment, 38(4), 261-269. https://doi.org/10.1027/1015-5759/a000663

39. Grage, L., & Cuellar, M. J. (2023). Did text-based news-media coverage about the COVID-19 pandemic increase vaccine uptake? A population-based study in Alaska. International Journal of Circumpolar Health, 82(1). https://doi.org/10.1080/22423982.2023.2213913

40. Hämäläinen A, Patovirta RL, Mauranen E, Hämäläinen S, Koivula I. Support among healthcare workers for the new mandatory seasonal influenza vaccination policy and its effects on vaccination coverage. Ann Med. 2021 Dec;53(1):384-390. doi: 10.1080/07853890.2021.1889022. PMID: 33616423; PMCID: PMC7901690.

41. Hauge SH, Bakken IJ, de Blasio BF, Håberg SE. Burden of medically attended influenza in Norway 2008-2017. Influenza Other Respir Viruses. May 2019;13(3):240-247. doi:10.1111/irv.12627

42. Ho HJ, Tan YR, Cook AR, Koh G, Tham TY, Anwar E, Hui Chiang GS, Lwin MO, Chen MI. Increasing Influenza and Pneumococcal Vaccination Uptake in Seniors Using Point-of-Care Informational Interventions in Primary Care in Singapore: A Pragmatic, Cluster-Randomized Crossover Trial. Am J Public Health. 2019 Dec;109(12):1776-1783. doi: 10.2105/AJPH.2019.305328. Epub 2019 Oct 17. PMID: 31622142; PMCID: PMC6836784.

43. Hofstetter AM, Vargas CY, Camargo S, Holleran S, Vawdrey DK, Kharbanda EO, Stockwell MS. Impacting delayed pediatric influenza vaccination: a randomized controlled trial of text message reminders. Am J Prev Med. 2015 Apr;48(4):392-401. doi: 10.1016/j.amepre.2014.10.023. PMID: 25812465.

44. Honda H, Sato Y, Yamazaki A, Padival S, Kumagai A, Babcock H. A successful strategy for increasing the influenza vaccination rate of healthcare workers without a mandatory policy outside of the United States: a multifaceted intervention in a Japanese tertiary care center. Infect Control Hosp Epidemiol. 2013 Nov;34(11):1194-200. doi: 10.1086/673452. Epub 2013 Sep 19. PMID: 24113604.

45. Humiston SG, Bennett NM, Long C, Eberly S, Arvelo L, Stankaitis J, Szilagyi PG. Increasing inner-city adult influenza vaccination rates: a randomized controlled trial. Public Health Rep. 2011 Jul-Aug;126 Suppl 2(Suppl 2):39-47. doi: 10.1177/00333549111260S206. PMID: 21812168; PMCID: PMC3113429.

46. Hurley LP, Beaty B, Lockhart S, Gurfinkel D, Breslin K, Dickinson M, Whittington MD, Roth H, Kempe A. RCT of Centralized Vaccine Reminder/Recall for Adults. Am J Prev Med. 2018 Aug;55(2):231-239. doi: 10.1016/j.amepre.2018.04.022. Epub 2018 Jun 15. PMID: 29910118.

47. Huth K, Benchimol EI, Aglipay M, Mack DR. Strategies to Improve Influenza Vaccination in Pediatric Inflammatory Bowel Disease Through Education and Access. Inflamm Bowel Dis. 2015 Aug;21(8):1761-8. doi: 10.1097/MIB.0000000000000425. PMID: 26199989.

48. Huynh S, Poduska P, Mallozzi T, Culler F. Mandatory influenza vaccination of health care workers: a first-year success implementation by a community health care system. Am J Infect Control. 2012 Oct;40(8):771-3. doi: 10.1016/j.ajic.2011.10.011. Epub 2012 Feb 9. PMID: 22325484.

49. Immunize. Communicating the Benefits of Influenza Vaccination. 2024. https://www.immunize.org/wp-content/uploads/catg.d/p3115.pdf

50. Isenor JE, Alia TA, Killen JL, Billard BA, Halperin BA, Slayter KL, McNeil SA, MacDougall D, Bowles SK. Impact of pharmacists as immunizers on influenza vaccination coverage in Nova Scotia, Canada. Hum Vaccin Immunother. 2016 May 3;12(5):1225-8. doi: 10.1080/21645515.2015.1127490. Epub 2016 Feb 10. PMID: 26863888; PMCID: PMC4963057.

51. Isenor JE, O'Reilly BA, Bowles SK. Evaluation of the impact of immunization policies, including the addition of pharmacists as immunizers, on influenza vaccination coverage in Nova Scotia, Canada: 2006 to 2016. BMC Public Health. 2018 Jun 26;18(1):787. doi: 10.1186/s12889-018-5697-x. PMID: 29940903; PMCID: PMC6019522.

52. Jane Barratt, & Megan Acton. (2021). Amplifying Civil Society Voices to Improve Rates of Adult Influenza Vaccination in Germany. www.ifa.ngo

53. Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD004879. doi: 10.1002/14651858.CD004879.pub5. PMID: 29388195; PMCID: PMC6491174.

54. Jiménez-García R, Herńndez-Barrera V, Rodríguez-Rieiro C, de Andrés AL, Miguel-Diez Jd, Trujillo IJ, Carrasco-Garrido P. Are age-based strategies effective in increasing influenza vaccination coverage?: the Spanish experience. Hum Vaccin Immunother. 2012 Feb;8(2):228-33. doi: 10.4161/hv.18433. Epub 2012 Feb 1. PMID: 22426373.

55. Jiménez-García R, Rodríguez-Rieiro C, Hernández-Barrera V, Lopez de Andres A, Rivero Cuadrado A, Rodriguez Laso A, Carrasco-Garrido P. Effectiveness of age-based strategies to increase influenza vaccination coverage among high risk subjects in Madrid (Spain). Vaccine. 2011 Apr 5;29(16):2840-5. doi: 10.1016/j.vaccine.2011.02.004. Epub 2011 Feb 18. PMID: 21334388.

56. Kaufman J, Attwell K, Tuckerman J, O'Sullivan J, Omer SB, Leask J, Regan A, Marshall H, Lee KJ, Snelling T, Perrett K, Wiley K, Giles ML, Danchin M. Feasibility and acceptability of the multi-component P3-MumBubVax antenatal intervention to promote maternal and childhood vaccination: A pilot study. Vaccine. 2020 May 19;38(24):4024-4031. doi: 10.1016/j.vaccine.2020.04.010. Epub 2020 Apr 19. PMID: 32321684.

57. Kiderlen TR, Trostdorf K, Delmastro N, Salomon A, Scholz CW, Späth-Schwalbe E, Mansmann V, Roll S, Reinwald M, de Wit M. Controlled non-randomised before-after study evaluating the impact of a focused recommendation card on vaccination rates of oncological patients-The Easy Vaccination in Oncology (EVO) strategy. Eur J Cancer Care (Engl). 2022 Nov;31(6):e13725. doi: 10.1111/ecc.13725. Epub 2022 Oct 11. PMID: 36221170.

58. Kim H, Lindley MC, Dube D, Kalayil EJ, Paiva KA, Raymond P. Evaluation of the impact of the 2012 Rhode Island health care worker influenza vaccination regulations: implementation process and vaccination coverage. J Public Health Manag Pract. 2015 May-Jun;21(3):E1-9. doi: 10.1097/PHH.0000000000000128. PMID: 25105280; PMCID: PMC4736136.

59. Kitt E, Burt S, Price SM, Satchell L, Offit PA, Sammons JS, Coffin SE. Implementation of a Mandatory Influenza Vaccine Policy: A 10-Year Experience. Clin Infect Dis. 2021 Jul 15;73(2):e290-e296. doi: 10.1093/cid/ciaa782. PMID: 33372217.

60. Kohli, M. A., Maschio, M., Cartier, S., Mould-Quevedo, J., & Fricke, F. U. (2022). The Cost-Effectiveness of Vaccination of Older Adults with an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Other Available Quadrivalent Vaccines in Germany. Vaccines, 10(9). https://doi.org/10.3390/vaccines10091386

61. Konstantinou P, Georgiou K, Kumar N, Kyprianidou M, Nicolaides C, Karekla M, Kassianos AP. Transmission of Vaccination Attitudes and Uptake Based on Social Contagion Theory: A Scoping Review. Vaccines (Basel). 2021 Jun 5;9(6):607. doi: 10.3390/vaccines9060607. PMID: 34198885; PMCID: PMC8229666.

62. Ksienski DS. Mandatory seasonal influenza vaccination or masking of British Columbia health care workers: Year 1. Can J Public Health. 2014 Jul 11;105(4):e312-6. doi: 10.17269/cjph.105.4346. PMID: 25166135; PMCID: PMC6972449.

63. Kumar S, Shah Z, Garfield S. Causes of Vaccine Hesitancy in Adults for the Influenza and COVID-19 Vaccines: A Systematic Literature Review. Vaccines (Basel). 2022 Sep 13;10(9):1518. doi: 10.3390/vaccines10091518. PMID: 36146596; PMCID: PMC9503596.

64. Laigle, V., Postma, M. J., Pavlovic, M., Cadeddu, C., Beck, E., Kapusniak, A., & Toumi, M. (2021). Vaccine market access pathways in the EU27 and the United Kingdom − analysis and recommendations for improvements. Vaccine, 39(39), 5706-5718. https://doi.org/10.1016/j.vaccine.2021.07.040

65. Larson HJ, Gakidou E, Murray CJL. The Vaccine-Hesitant Moment. N Engl J Med. 2022 Jul 7;387(1):58-65. doi: 10.1056/NEJMra2106441. Epub 2022 Jun 29. PMID: 35767527; PMCID: PMC9258752.

66. Lawlor, R., Wilsdon, T., Rémy-Blanc, V., Nogal, A. Á., & Pana, A. (2022). A review of the sustainability of vaccine funding across Europe and implications for post-COVID policymaking. In Health Policy (Vol. 126, Issue 10, pp. 956-969). Elsevier Ireland Ltd. https://doi.org/10.1016/j.healthpol.2022.08.004

67. Leask J, Kinnersley P, Jackson C, Cheater F, Bedford H, Rowles G. Communicating with parents about vaccination: a framework for health professionals. BMC Pediatr. 2012 Sep 21;12:154. doi: 10.1186/1471-2431-12-154. PMID: 22998654; PMCID: PMC3480952.

68. Leibu R, Maslow J. Effectiveness and acceptance of a health care-based mandatory vaccination program. J Occup Environ Med. 2015 Jan;57(1):58-61. doi: 10.1097/JOM.0000000000000294. PMID: 25563540.

69. Leitmeyer K, Buchholz U, Kramer M, Schenkel K, Stahlhut H, Köllstadt M, Haas W, Meyer C. Influenza vaccination in German health care workers: effects and findings after two rounds of a nationwide awareness campaign. Vaccine. 2006 Nov 17;24(47-48):7003-8. doi: 10.1016/j.vaccine.2006.04.040. Epub 2006 May 11. PMID: 16730866.

70. Li A, Chan YH, Liew MF, Pandey R, Phua J. Improving Influenza Vaccination Coverage Among Patients With COPD: A Pilot Project. Int J Chron Obstruct Pulmon Dis. 2019 Nov 15;14:2527-2533. doi: 10.2147/COPD.S222524. PMID: 31814718; PMCID: PMC6863121.

71. Lin CJ, Nowalk MP, Zimmerman RK, Moehling KK, Conti T, Allred NJ, Reis EC. Reducing Racial Disparities in Influenza Vaccination Among Children With Asthma. J Pediatr Health Care. 2016 May-Jun;30(3):208-15. doi: 10.1016/j.pedhc.2015.06.006. Epub 2015 Aug 5. PMID: 26254743; PMCID: PMC4744151.

72. Lin CJ, Nowalk MP, Zimmerman RK. Estimated costs associated with improving influenza vaccination for health care personnel in a multihospital health system. Jt Comm J Qual Patient Saf. 2012 Feb;38(2):67-72. doi: 10.1016/s1553-7250(12)38009-4. PMID: 22372253.

73. Llupià A, Mena G, Olivé V, Quesada S, Aldea M, Sequera VG, Ríos J, García-Basteiro AL, Varela P, Bayas JM, Trilla A. Evaluating influenza vaccination campaigns beyond coverage: a before-after study among health care workers. Am J Infect Control. 2013 Aug;41(8):674-8. doi: 10.1016/j.ajic.2013.04.006. PMID: 23896285.

74. Matias, G., Taylor, R.J., Haguinet, F. et al. Modelling estimates of age-specific influenza-related hospitalisation and mortality in the United Kingdom. BMC Public Health 16, 481 (2016). https://doi.org/10.1186/s12889-016-3128-4

75. Maurel Marine, Howard Jennifer, Kissling Esther, Pozo Francisco, Pérez-Gimeno Gloria, Buda Silke, et al.. Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024. Euro Surveill. 2024;29(8):pii=2400089. https://doi.org/10.2807/1560-7917.ES.2024.29.8.2400089

76. McAuliffe K, Peddecord KM, Wang W, Ralston K, Deguire M, Waters-Montijo K, Sawyer MH. Influenza vaccination and its association with clinic use of evidence-based practices and individual patient characteristics, San Diego County, 2009. J Public Health Manag Pract. 2013 Mar-Apr;19(2):178-86. doi: 10.1097/PHH.0b013e318259e735. PMID: 23358297.

77. McGinnis JM, Jones R, Hillis C, Kokus H, Thomas H, Thomas J, Alyafi M, Bernard L, Eiriksson LR, Elit LM, Hirte H, Jimenez W, Reade CJ, Kumar Tyagi N, Helpman L. A pneumococcal pneumonia and influenza vaccination quality improvement program for women receiving chemotherapy for gynecologic cancers at a major tertiary cancer Centre. Gynecol Oncol. 2021 Apr;161(1):236-243. doi: 10.1016/j.ygyno.2021.01.014. Epub 2021 Jan 29. PMID: 33526258.

78. Miller BL, Ahmed F, Lindley MC, Wortley PM. Increases in vaccination coverage of healthcare personnel following institutional requirements for influenza vaccination: a national survey of U.S. hospitals. Vaccine. 2011 Nov 21;29(50):9398-403. doi: 10.1016/j.vaccine.2011.09.047. Epub 2011 Sep 22. PMID: 21945495.

79. Mustafa M, Al-Khal A, Al Maslamani M, Al Soub H. Improving influenza vaccination rates of healthcare workers: a multipronged approach in Qatar. East Mediterr Health J. 2017 Jun 14;23(4):303-310. doi: 10.26719/2017.23.4.303. PMID: 28634981.

80. Nehme EK, Delphia M, Cha EM, Thomas M, Lakey D. Promoting Influenza Vaccination Among an ACA Health Plan Subscriber Population: A Randomized Trial. Am J Health Promot. 2019 Jul;33(6):916-920. doi: 10.1177/0890117118823157. Epub 2019 Jan 10. PMID: 30630342.

81. Neufeind J, Wenchel R, Boedeker B, Wicker S, Wichmann O. Monitoring influenza vaccination coverage and acceptance among health-care workers in German hospitals - results from three seasons. Hum Vaccin Immunother. 2021 Mar 4;17(3):664-672. doi: 10.1080/21645515.2020.1801072. Epub 2020 Oct 30. PMID: 33124954; PMCID: PMC7993141.

82. Neufeind, J., Wenchel, R., Boedeker, B., Wicker, S., & Wichmann, O. (2021). Monitoring influenza vaccination coverage and acceptance among health-care workers in German hospitals-results from three seasons. Human Vaccines and Immunotherapeutics, 17(3), 664-672. https://doi.org/10.1080/21645515.2020.1801072

83. Norbury M, Fawkes N, Guthrie B. Impact of the GP contract on inequalities associated with influenza immunisation: a retrospective population-database analysis. Br J Gen Pract. 2011 Jul;61(588):e379-85. doi: 10.3399/bjgp11X583146. PMID: 21722444; PMCID: PMC3123499.

84. Nowalk MP, Lin CJ, Hannibal K, Reis EC, Gallik G, Moehling KK, Huang HH, Allred NJ, Wolfson DH, Zimmerman RK. Increasing childhood influenza vaccination: a cluster randomized trial. Am J Prev Med. 2014 Oct;47(4):435-43. doi: 10.1016/j.amepre.2014.07.003. Epub 2014 Aug 8. PMID: 25113138; PMCID: PMC4208625.

85. Nowalk MP, Moehling KK, Zhang S, Raviotta JM, Zimmerman RK, Lin CJ. Using the 4 Pillars to increase vaccination among high-risk adults: who benefits? Am J Manag Care. 2017 Nov;23(11):651-655. PMID: 29182350; PMCID: PMC6166239.

86. O'Leary ST, Pyrzanowski J, Brewer SE, Sevick C, Miriam Dickinson L, Dempsey AF. Effectiveness of a multimodal intervention to increase vaccination in obstetrics/gynecology settings. Vaccine. 2019 Jun 6;37(26):3409-3418. doi: 10.1016/j.vaccine.2019.05.034. Epub 2019 May 15. PMID: 31103367.

87. Pasté, M., Stoffel, M., Bardone, C., Baron-Papillon, F., Czwarno, A., Galbraith, H., Gastineau, T., Germay, O., Gonzo, D., Juvin, P., Kissane, J., Laigle, V., Mlynarczyk, P., van Hoof, P., Wettendorff, M., & Quilici, S. (2022). Addressing vaccine supply challenges in Europe: Expert industry perspective and recommendations. In Health Policy (Vol. 126, Issue 1, pp. 35-42). Elsevier Ireland Ltd. https://doi.org/10.1016/j.healthpol.2021.11.006

88. Perlin JB, Septimus EJ, Cormier SB, Moody JA, Hickok JD, Bracken RM. Developing a program to increase seasonal influenza vaccination of healthcare workers: lessons from a system of community hospitals. J Healthc Qual. 2013 Nov-Dec;35(6):5-15. doi: 10.1111/jhq.12005. Epub 2013 Mar 7. PMID: 23470232.

89. Peschke M, Hagel S, Rose N, Pletz MW, Steiner A. Seasonal Influenza Vaccination at a German University Hospital: Distinguishing Barriers Between Occupational Groups. Front Med (Lausanne). 2022 May 27;9:873231. doi: 10.3389/fmed.2022.873231. PMID: 35692542; PMCID: PMC9184714.

90. Peschke, M., Hagel, S., Rose, N., Pletz, M. W., & Steiner, A. (2022). Seasonal Influenza Vaccination at a German University Hospital: Distinguishing Barriers Between Occupational Groups. Frontiers in Medicine, 9. https://doi.org/10.3389/fmed.2022.873231

91. Podczervinski S, Stednick Z, Helbert L, Davies J, Jagels B, Gooley T, Casper C, Pergam SA. Employee influenza vaccination in a large cancer center with high baseline compliance rates: comparison of carrot versus stick approaches. Am J Infect Control. 2015 Mar 1;43(3):228-33. doi: 10.1016/j.ajic.2014.11.025. PMID: 25728148; PMCID: PMC4372134.

92. Preaud, E., Durand, L., Macabeo, B. et al. Annual public health and economic benefits of seasonal influenza vaccination: a European estimate. BMC Public Health 14, 813 (2014). https://doi.org/10.1186/1471-2458-14-813

93. Rajaram S, Steffey A, Blak B, Hickman M, Christensen H, Caspard H. Uptake of childhood influenza vaccine from 2012-2013 to 2014-2015 in the UK and the implications for high-risk children: a retrospective observational cohort study. BMJ Open. 2016 Aug 1;6(8):e010625. doi: 10.1136/bmjopen-2015-010625. PMID: 27481618; PMCID: PMC4985803.

94. Regan AK, Bloomfield L, Peters I, Effler PV. Randomized Controlled Trial of Text Message Reminders for Increasing Influenza Vaccination. Ann Fam Med. 2017 Nov;15(6):507-514. doi: 10.1370/afm.2120. PMID: 29133488; PMCID: PMC5683861.

95. RKI. (2022). Flu Vaccination: Vaccination during pregnancy protects both mother and unborn child.

96. RKI. (2023). Epidemiologisches Bulletin: Recommendations by the Standing Committee on Vaccination (STIKO) at the Robert Koch Institute - 2023. https://doi.org/10.25646/10829

97. Robert Koch Institute. (2022). Epidemiologisches Bulletin 49/22. https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2022/Ausgaben/49_22.html

98. Robert Koch-Institut (2019) Bericht zur Epidemiologie der Influenza in Deutschland, Saison 2018/19. https://edoc.rki.de/bitstream/handle/176904/6253/RKI_Influenzabericht_2018-19.pdf?sequence=1&isAllowed=y

99. Roca B, Herrero E, Resino E, Torres V, Penades M, Andreu C. Impact of education program on influenza vaccination rates in Spain. Am J Manag Care. 2012 Dec 1;18(12):e446-52. PMID: 23286674.

100. Sanftenberg L, Kuehne F, Anraad C, Jung-Sievers C, Dreischulte T, Gensichen J. Assessing the impact of shared decision making processes on influenza vaccination rates in adult patients in outpatient care: A systematic review and meta-analysis. Vaccine. 2021 Jan 8;39(2):185-196. doi: 10.1016/j.vaccine.2020.12.014. Epub 2020 Dec 14. PMID: 33334617.

101. Sanftenberg, L., Brombacher, F., Schelling, J., Klug, S. J., & Gensichen, J. (2019). Increasing Influenza Vaccination Rates in People With Chronic Illness. Deutsches Arzteblatt International, 116(39). https://doi.org/10.3238/arztebl.2019.0645

102. Schmid P, Rauber D, Betsch C, Lidolt G, Denker ML. Barriers of Influenza Vaccination Intention and Behavior - A Systematic Review of Influenza Vaccine Hesitancy, 2005 - 2016. PLoS One. 2017 Jan 26;12(1):e0170550. doi: 10.1371/journal.pone.0170550. PMID: 28125629; PMCID: PMC5268454.

103. Schmidt-Ott, R., Molnar, D., Anastassopoulou, A., Yanni, E., Krumm, C., Bekkat-Berkani, R., Dos Santos, G., Henneke, P., Knuf, M., Schwehm, M., & Eichner, M. (2020). Assessing direct and indirect effects of pediatric influenza vaccination in Germany by individual-based simulations. Human Vaccines and Immunotherapeutics, 16(4), 836-845. https://doi.org/10.1080/21645515.2019.1682843

104. Scholz S, Damm O, Schneider U, Ultsch B, Wichmann O, Greiner W. Epidemiology and cost of seasonal influenza in Germany - a claims data analysis. BMC Public Health. 2019 Aug 13;19(1):1090. doi: 10.1186/s12889-019-7458-x. PMID: 31409319; PMCID: PMC6693205.

105. Scholz, S. M., Weidemann, F., Damm, O., Ultsch, B., Greiner, W., & Wichmann, O. (2021). Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany. Value in Health, 24(1), 32-40. https://doi.org/10.1016/j.jval.2020.05.022

106. Schulte K, Schierke H, Tamayo M, Hager L, Engehausen R, Raspe M, Hübner RH, Schlieper G, Borzikowsky C, Urbschat A, Auerswald S, Kunzendorf U, Feldkamp T. Strategies for Improving Influenza Vaccination Rates in Patients with Chronic Renal Disease. Dtsch Arztebl Int. 2019 Jun 10;116(23-24):413-419. doi: 10.3238/arztebl.2019.0413. PMID: 31366435; PMCID: PMC6683446.

107. Schumacher S, Salmanton-García J, Cornely OA, Mellinghoff SC. Increasing influenza vaccination coverage in healthcare workers: a review on campaign strategies and their effect. Infection. 2021 Jun;49(3):387-399. doi: 10.1007/s15010-020-01555-9. Epub 2020 Dec 7. PMID: 33284427; PMCID: PMC7720031.

108. Schumacher S, Salmanton-García J, Liekweg A, Rolfes M, Seidel D, Mellinghoff SC, Cornely OA. Increasing influenza vaccination coverage in healthcare workers: analysis of an intensified on-site vaccination campaign during the COVID-19 pandemic. Infection. 2023 Oct;51(5):1417-1429. doi: 10.1007/s15010-023-02007-w. Epub 2023 Feb 28. PMID: 36853494; PMCID: PMC9972307.

109. Schumacher, S., Salmanton-García, J., Cornely, O. A., & Mellinghoff, S. C. (2021). Increasing influenza vaccination coverage in healthcare workers: a review on campaign strategies and their effect. In Infection (Vol. 49, Issue 3, pp. 387-399). Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/s15010-020-01555-9

110. Schumacher, S., Salmanton-García, J., Liekweg, A., Rolfes, M., Seidel, D., Mellinghoff, S. C., & Cornely, O. A. (2023). Increasing influenza vaccination coverage in healthcare workers: analysis of an intensified on-site vaccination campaign during the COVID-19 pandemic. Infection, 51(5), 1417-1429. https://doi.org/10.1007/s15010-023-02007-w

111. Sheikh, S., Biundo, E., Courcier, S., Damm, O., Launay, O., Maes, E., Marcos, C., Matthews, S., Meijer, C., Poscia, A., Postma, M., Saka, O., Szucs, T., & Begg, N. (2018). A report on the status of vaccination in Europe. In Vaccine (Vol. 36, Issue 33, pp. 4979-4992). Elsevier Ltd. https://doi.org/10.1016/j.vaccine.2018.06.044

112. Statistiches Bundesamt (2023) Code: 12411-0006. Population: Germany, reference date, age, nationality / sex / marital status

113. Statistiches Bundesamt (2023) Code: 12612-0005. Live births: Germany, years, age of the mother, live birth order

114. Statistiches Bundesamt (2023) Code: 23621-0002 Health personnel: Germany, years, facilities, sex, occupations in healthcare

115. Statistiches Bundesamt (2023) Employed and employment rate1 by sex and age. https://www.destatis.de/EN/Themes/Labour/Labour-Market/Employment/Tables/et-etq-2021.html

116. Statistiches Bundesamt (2023) Medical facilities, hospital beds and movement of patient. https://www.destatis.de/EN/Themes/Society-Environment/Health/Hospitals/Tables/gd-hospitals-years.html

117. Statistisches Bundesamt (2025) Code: 12621-0001 Life table (period life table): Germany, period of years, sex, completed age

118. Steffen, A., Rieck, T., & Siedler, A. (2021). Monitoring of influenza vaccination coverage among pregnant women in Germany based on nationwide outpatient claims data: Findings for seasons 2014/15 to 2019/20. Vaccines, 9(5). https://doi.org/10.3390/vaccines9050485

119. Stöckeler, A. M., Schuster, P., Zimmermann, M., & Hanses, F. (2021). Influenza vaccination coverage among emergency department personnel is associated with perception of vaccination and side effects, vaccination availability on site and the COVID-19 pandemic. PLoS ONE, 16(11 November). https://doi.org/10.1371/journal.pone.0260213

120. Stockwell MS, Kharbanda EO, Martinez RA, Vargas CY, Vawdrey DK, Camargo S. Effect of a text messaging intervention on influenza vaccination in an urban, low-income pediatric and adolescent population: a randomized controlled trial. JAMA. 2012 Apr 25;307(16):1702-8. doi: 10.1001/jama.2012.502. PMID: 22535855.

121. Stuurman, A. L., Rizzo, C., & Haag, M. (2021). Investigating the procurement system for understanding seasonal influenza vaccine brand availability in Europe. PLoS ONE, 16(4 April). https://doi.org/10.1371/journal.pone.0248943

122. Szilagyi PG, Schaffer S, Rand CM, Goldstein NPN, Hightower AD, Younge M, Eagan A, Blumkin A, Albertin CS, DiBitetto K, Concannon C, Vincelli P, Yoo BK, Humiston SG. Impact of elementary school-located influenza vaccinations: A stepped wedge trial across a community. Vaccine. 2018 May 11;36(20):2861-2869. doi: 10.1016/j.vaccine.2018.03.047. Epub 2018 Apr 17. PMID: 29678459.

123. Szilagyi PG, Schaffer S, Rand CM, Vincelli P, Eagan A, Goldstein NP, Hightower AD, Younge M, Blumkin A, Albertin CS, Yoo BK, Humiston SG. School-Located Influenza Vaccinations: A Randomized Trial. Pediatrics. 2016 Nov;138(5):e20161746. doi: 10.1542/peds.2016-1746. PMID: 27940785.

124. Tielsch Goddard A, Borkowski V, Konesky A, Bennhoff A. Taking Action on Asthma: Increasing Influenza Vaccination Rates in Pediatric Asthma Through Quality Improvement. J Pediatr Health Care. 2019 Nov-Dec;33(6):653-662. doi: 10.1016/j.pedhc.2019.04.016. Epub 2019 Jun 26. PMID: 31253452.

125. United Nations, Department of Economic and Social Affairs, Population Division (2024). Total Births by Sex. World Population Prospects: The 2024 Revision. https://population.un.org/dataportal/data/indicators/57/locations/276/start/1950/end/2101/table/pivotbylocation?df=74df7c49-7f26-4648-ba89-853c41bc4f85

126. Vanessa Alphons, & Jane Barratt. (2020). Influencing Policy to Improve Adult Vaccination in Germany.

127. Welch VL, Metcalf T, Macey R, Markus K, Sears AJ, Enstone A, Langer J, Srivastava A, Cane A, Wiemken TL. Understanding the Barriers and Attitudes toward Influenza Vaccine Uptake in the Adult General Population: A Rapid Review. Vaccines (Basel). 2023 Jan 13;11(1):180. doi: 10.3390/vaccines11010180. PMID: 36680024; PMCID: PMC9861815.

128. Wicker S, Rabenau HF, Doerr HW, Allwinn R. Influenza vaccination compliance among health care workers in a German university hospital. Infection. 2009 Jun;37(3):197-202. doi: 10.1007/s15010-008-8200-2. Epub 2008 Dec 10. PMID: 19139807.

129. Wicker, S., & Rabenau, H. F. (2010). A Patient Safety Issue: Mandatory Influenza Vaccination for Health Care Workers. Procedia in Vaccinology, 2(1), 101-105. https://doi.org/10.1016/j.provac.2010.03.018

130. Wilsdon T, Lawlor R, Li L, Rafila A, García Rojas A. The impact of vaccine procurement methods on public health in selected European countries. Expert Rev Vaccines. 2020 Feb;19(2):123-132. doi: 10.1080/14760584.2020.1717952. Epub 2020 Jan 28. PMID: 31990601.

131. Wong VWY, Fong DYT, Lok KYW, Wong JYH, Sing C, Choi AY, Yuen CYS, Tarrant M. Brief education to promote maternal influenza vaccine uptake: A randomized controlled trial. Vaccine. 2016 Oct 17;34(44):5243-5250. doi: 10.1016/j.vaccine.2016.09.019. Epub 2016 Sep 22. PMID: 27667330

132. Yeung KHT, Tarrant M, Chan KCC, Tam WH, Nelson EAS. Increasing influenza vaccine uptake in children: A randomised controlled trial. Vaccine. 2018 Sep 5;36(37):5524-5535. doi: 10.1016/j.vaccine.2018.07.066. Epub 2018 Aug 2. PMID: 30078745.

133. Yudin MH, Mistry N, De Souza LR, Besel K, Patel V, Blanco Mejia S, Bernick R, Ryan V, Urquia M, Beigi RH, Moniz MH, Sgro M. Text messages for influenza vaccination among pregnant women: A randomized controlled trial. Vaccine. 2017 Feb 1;35(5):842-848. doi: 10.1016/j.vaccine.2016.12.002. Epub 2017 Jan 3. PMID: 28062124.

134. Zheng, Y., & Barratt, J. (2020). Changing the Conversation on Adult Influenza Vaccination, Campaign Overview: Germany.

135. Zimmerman RK, Nowalk MP, Lin CJ, Hannibal K, Moehling KK, Huang HH, Matambanadzo A, Troy J, Allred NJ, Gallik G, Reis EC. Cluster randomized trial of a toolkit and early vaccine delivery to improve childhood influenza vaccination rates in primary care. Vaccine. 2014 Jun 17;32(29):3656-63. doi: 10.1016/j.vaccine.2014.04.057. Epub 2014 Apr 29. PMID: 24793941; PMCID: PMC4070849.